H. Dubben

发表

Systematic review of publication bias in studies on publication bias

H. Dubben, H. Beck-Bornholdt, 2005, BMJ : British Medical Journal.

Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy.

B. Beuthien-Baumann, W. Enghardt, M. Baumann, 2001 .

No Effect of the Hemoglobin Solution HBOC-201 on the Response of the Rat R1H Tumor to Fractionated Irradiation

H. Dubben, A. Raabe, M. Hommel, 2005, Strahlentherapie und Onkologie.

New methods to deal with publication bias

H. Dubben, 2009, BMJ : British Medical Journal.

Linear-quadratic analysis of tumor response to fractionated radiotherapy: a study on human squamous cell carcinoma xenografts

M. Baumann, H. Dubben, C. Petersen, 1998, Strahlentherapie und Onkologie.

[A linear quadratic analysis of the effect of different fractionation patterns on local tumor control: a study on human squamous-cell carcinomas in nude mice].

M. Baumann, H. Dubben, C. Petersen, 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Linear-quadratic analysis of tumour response to fractionated radiotherapy: a study on human squamous cell carcinoma xenografts.

M. Baumann, H. Dubben, C. Petersen, 1998 .

Radiobiological hypoxia, oxygen tension, interstitial fluid pressure and relative viable tumour area in two human squamous cell carcinomas in nude mice during fractionated radiotherapy.

B. Beuthien-Baumann, W. Enghardt, M. Baumann, 2001, Acta oncologica.

Tumor volume: a basic and specific response predictor in radiotherapy.

H. Thames, H. Dubben, H. Beck-Bornholdt, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Split-Course Radiotherapy: Where Do We Stand?

H. Dubben, H. Beck-Bornholdt, A. Krüll, 2001, Strahlentherapie und Onkologie.

Basic Principles of Science in Medical Education—Development and Implementation of a Two Week Introductory Track

H. Dubben, L. Kriston, A. Guse, 2016 .

Hyperfractionation: where do we stand?

H. Dubben, H. Beck-Bornholdt, H. Willers, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Impact of Treatment Acceleration and its Timing on the Response of the Rhabdomyosarcoma R1H of the Rat to Fractionated Irradiation

H. Dubben, H. Beck-Bornholdt, A. Raabe, 2001, Strahlentherapie und Onkologie.

Different nucleolar antigen expression in resting and proliferating human lymphocytes as studied by fluorescence microscopy and flow cytometry

H. Dubben, 1990, Cell and tissue kinetics.

[The value of radiotherapy in treatment of meningeal melanocytoma].

M. Tatagiba, D. Rades, H. Dubben, 2002, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

authors to provide as soon as possible a complete and actuarial analysis (5) of the late normal tissue effects.

H. Dubben, H. Beck-Bornholdt, S. Pii, 2001 .

Local control, TCD50 and dose-time prescription habits in radiotherapy of head and neck tumours

H. Dubben, 1994 .

[Authorship of scientific publications. Audit of the periodical "Strahlentherapie und Onkologie"].

H. Dubben, H. Beck-Bornholdt, A. Schmidt, 2001, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

Trials of prostate-cancer screening are not worthwhile.

H. Dubben, 2009, The Lancet. Oncology.

Potential pitfalls in the use of p-values and in interpretation of significance levels.

H P Beck-Bornholdt, H H Dubben, H. Dubben, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Re: Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

H. Dubben, Hans-Hermann Dubben, 2004, Journal of the National Cancer Institute.

Overall treatment time in the radiotherapy of transitional cell cancer of the bladder.

H. Dubben, M. Kleineidam, 1992, Radiotherapy and Oncology.

Two or three component dose-time curves for bladder cancer

L. Marks, B. Maciejewski, H. Dubben, 1992 .

Influence of the timing of a concomitant boost during fractionated irradiation of rat rhabdomyosarcoma R1H.

H. Dubben, H. Beck-Bornholdt, 1993, Acta oncologica.

Is the Pope an alien?

Hans-Peter Beck-Bornholdt, H. Dubben, H. Beck-Bornholdt, 1996, Nature.

No clinical evidence for the influence of overall treatment time on TCD50 of head and neck tumours.

H. Dubben, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Oxygen enhancement ratio of a murine fibrosarcoma.

H. Dubben, H. Beck-Bornholdt, 1992, International journal of radiation oncology, biology, physics.

Is there sufficient evidence of hypersensitivity to low doses in radiotherapy?

H. Dubben, S. Brackrock, B. Roper, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.